FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966379378> ?p ?o ?g. }

• W1966379378 endingPage "47" @default.
• W1966379378 startingPage "38" @default.
• W1966379378 abstract "Aims New drugs for type 2 diabetes need to demonstrate their cardiovascular safety, due regulatory requirements from the Food and Drug Administration. For this reason, glucagon-like peptide-1 receptor agonists (GLP-1 RA) are currently undergoing large-scale, long-term randomized trials specifically designed for cardiovascular outcomes. Aim of the present meta-analysis of randomized clinical trials is the assessment of the effects of GLP-1 RA on major cardiovascular events (MACE), mortality and cardiovascular risk factors. Methods A meta-analysis was performed including all trials with a duration of at least 6 months, comparing a GLP-1 RA with a non-GLP-1 RA agent in type 2 diabetes. MACE and mortality were retrieved and combined to calculate Mantel–Haenzel odds ratio (MH-OR). Furthermore, data on endpoint systolic and diastolic blood pressure, total and high-density lipoprotein (HDL) cholesterol and triglyceride were collected. Results Of 37 selected trials, 33 reported information on MACE, and 25 reported at least one event. The difference in the incidence of MACE between GLP-1 RA and comparators did not reach statistical significance [MH-OR 0.78 (0.54–1.13), p = 0.18]. GLP-1 RA were associated with a significant reduction in the incidence of MACE in comparisons with placebo and pioglitazone, with a non-significant trend towards reduction in DPP4i-controlled studies. No significant effect of GLP-1 RA was observed on mortality, although a non-significant favourable trend was observed in comparisons with placebo. Conclusions The present meta-analysis confirms the cardiovascular safety of GLP-1 RA, at least in the short term and in low-risk individuals. GLP-1 RA could have a beneficial effect on the incidence of MACE, at least in comparison with placebo." @default.
• W1966379378 created "2016-06-24" @default.
• W1966379378 creator A5014780759 @default.
• W1966379378 creator A5030847814 @default.
• W1966379378 creator A5059413618 @default.
• W1966379378 creator A5059685674 @default.
• W1966379378 creator A5086210064 @default.
• W1966379378 date "2013-07-28" @default.
• W1966379378 modified "2023-09-27" @default.
• W1966379378 title "Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials" @default.
• W1966379378 cites W1964435302 @default.
• W1966379378 cites W1973442218 @default.
• W1966379378 cites W1986215651 @default.
• W1966379378 cites W2004932692 @default.
• W1966379378 cites W2005501262 @default.
• W1966379378 cites W2027276740 @default.
• W1966379378 cites W2051279660 @default.
• W1966379378 cites W2069417225 @default.
• W1966379378 cites W2085458648 @default.
• W1966379378 cites W2086177834 @default.
• W1966379378 cites W2098459806 @default.
• W1966379378 cites W2109677274 @default.
• W1966379378 cites W2115653936 @default.
• W1966379378 cites W2139171405 @default.
• W1966379378 cites W2140682563 @default.
• W1966379378 cites W2141132900 @default.
• W1966379378 cites W2145270758 @default.
• W1966379378 cites W2152835319 @default.
• W1966379378 cites W2152969995 @default.
• W1966379378 cites W2155121555 @default.
• W1966379378 cites W2157665742 @default.
• W1966379378 cites W2157823046 @default.
• W1966379378 cites W4214661190 @default.
• W1966379378 cites W4239111797 @default.
• W1966379378 doi "https://doi.org/10.1111/dom.12175" @default.
• W1966379378 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23829656" @default.
• W1966379378 hasPublicationYear "2013" @default.
• W1966379378 type Work @default.
• W1966379378 sameAs 1966379378 @default.
• W1966379378 citedByCount "156" @default.
• W1966379378 countsByYear W19663793782013 @default.
• W1966379378 countsByYear W19663793782014 @default.
• W1966379378 countsByYear W19663793782015 @default.
• W1966379378 countsByYear W19663793782016 @default.
• W1966379378 countsByYear W19663793782017 @default.
• W1966379378 countsByYear W19663793782018 @default.
• W1966379378 countsByYear W19663793782019 @default.
• W1966379378 countsByYear W19663793782020 @default.
• W1966379378 countsByYear W19663793782021 @default.
• W1966379378 countsByYear W19663793782022 @default.
• W1966379378 countsByYear W19663793782023 @default.
• W1966379378 crossrefType "journal-article" @default.
• W1966379378 hasAuthorship W1966379378A5014780759 @default.
• W1966379378 hasAuthorship W1966379378A5030847814 @default.
• W1966379378 hasAuthorship W1966379378A5059413618 @default.
• W1966379378 hasAuthorship W1966379378A5059685674 @default.
• W1966379378 hasAuthorship W1966379378A5086210064 @default.
• W1966379378 hasConcept C126322002 @default.
• W1966379378 hasConcept C134018914 @default.
• W1966379378 hasConcept C142724271 @default.
• W1966379378 hasConcept C156957248 @default.
• W1966379378 hasConcept C164705383 @default.
• W1966379378 hasConcept C168563851 @default.
• W1966379378 hasConcept C204787440 @default.
• W1966379378 hasConcept C27081682 @default.
• W1966379378 hasConcept C2777180221 @default.
• W1966379378 hasConcept C2779829264 @default.
• W1966379378 hasConcept C2780400711 @default.
• W1966379378 hasConcept C2780533449 @default.
• W1966379378 hasConcept C2780739214 @default.
• W1966379378 hasConcept C500558357 @default.
• W1966379378 hasConcept C555293320 @default.
• W1966379378 hasConcept C71924100 @default.
• W1966379378 hasConcept C84393581 @default.
• W1966379378 hasConcept C95190672 @default.
• W1966379378 hasConceptScore W1966379378C126322002 @default.
• W1966379378 hasConceptScore W1966379378C134018914 @default.
• W1966379378 hasConceptScore W1966379378C142724271 @default.
• W1966379378 hasConceptScore W1966379378C156957248 @default.
• W1966379378 hasConceptScore W1966379378C164705383 @default.
• W1966379378 hasConceptScore W1966379378C168563851 @default.
• W1966379378 hasConceptScore W1966379378C204787440 @default.
• W1966379378 hasConceptScore W1966379378C27081682 @default.
• W1966379378 hasConceptScore W1966379378C2777180221 @default.
• W1966379378 hasConceptScore W1966379378C2779829264 @default.
• W1966379378 hasConceptScore W1966379378C2780400711 @default.
• W1966379378 hasConceptScore W1966379378C2780533449 @default.
• W1966379378 hasConceptScore W1966379378C2780739214 @default.
• W1966379378 hasConceptScore W1966379378C500558357 @default.
• W1966379378 hasConceptScore W1966379378C555293320 @default.
• W1966379378 hasConceptScore W1966379378C71924100 @default.
• W1966379378 hasConceptScore W1966379378C84393581 @default.
• W1966379378 hasConceptScore W1966379378C95190672 @default.
• W1966379378 hasIssue "1" @default.
• W1966379378 hasLocation W19663793781 @default.
• W1966379378 hasLocation W19663793782 @default.
• W1966379378 hasOpenAccess W1966379378 @default.
• W1966379378 hasPrimaryLocation W19663793781 @default.

• next